KerrP., A Philosophical Investigation (New York: Bantam Books, 1995): at 34.
2.
KatzmanG. L., “Incidental Findings on Brain Magnetic Resonance Imaging from 1000 Asymptomatic Volunteers,”JAMA282, no. 1 (1999): 36–39.
3.
GrossmanR. I.BernatJ. L., “Incidental Research Imaging Findings: Pandora's Costly Box,”Neurology62, no. 6 (2004): 849–850; IllesJ., “On the Contents of Pandora's Box of Incidental Findings in Brain Imaging Research,”Nature Clinical Practice Neurology2, no. 2 (2006): 60–61.
4.
IllesJ.ChinV., “Trust and Reciprocity: Foundational-Principles in Human Subjects Imaging Research,”Canadian Journal of Neurological Sciences34, no. 1 (2007): 3–4.
5.
KimB. S., “Incidental Findings on Pediatric MR Images of the Brain,”American Journal of Neuroradiology23, no. 10 (2002): 1674–1677.
6.
IllesJ., “Practical Approaches to Incidental Findings on Brain Imaging Research,”Neurology70, no. 5 (2008): 384–390.
7.
Id., at 2.
8.
MamourianA., “Incidental Findings on Research Functional MR Images: Should We Look?”American Journal of Neuroradiology25, no. 4 (2004): 520–522.
9.
WeberF.KnopfH., “Incidental Findings in Magnetic Resonance Imaging of Healthy Young Men,”Journal of Neurological Sciences240, nos. 1–2 (2006): 81–84.
10.
IllesJ.KirschenM., “New Prospects and Ethical Challenges for Neuroimaging Within and Outside the Health Care System,”American Journal of Neuroradiology24, no. 10 (2003): 1932–1934; EatonM. L.IllesJ., “Commercializing Cognitive Neurotechnology: The Ethical Terrain,”Nature Biotechnology25, no. 4 (2007): 393–397.
11.
IllesJ., “Discovery and Disclosure of Incidental Findings on Brain MRI in Research,”Journal of Magnetic Resonance Imaging20, no. 5 (2004): 743–747.
KirschenM. P., “Subjects' Expectations in Neuroimaging Research,”Journal of Magnetic Resonance Imaging23, no. 2 (2006): 205–209.
14.
HilgenbergS., “Transformation: From Medical Student to Patient,”Annals of Internal Medicine144, no. 10 (2006): 779–780.
15.
Id., at 6.
16.
KassN. E., “Balancing Justice and Autonomy in Clinical Research with Healthy Volunteers,”Clinical Pharmacology and Therapeutics82, no. 2 (2007): 219–227; MillerF. G., “Ethical Issues in Research with Healthy Volunteers: Risk-Benefit Assessment,”Clinical Pharmacology and Therapeutics74, no. 6 (2003): 513–515.